These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26353451)

  • 1. [Study of lamotrigine efficacy on behavior disorders affecting patients with severe mental retardation].
    Kubagawa T; Furusho J; Isozaki Y
    No To Hattatsu; 2015 Jul; 47(4):289-92. PubMed ID: 26353451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation.
    Ettinger AB; Weisbrot DM; Saracco J; Dhoon A; Kanner A; Devinsky O
    Epilepsia; 1998 Aug; 39(8):874-7. PubMed ID: 9701379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine.
    Beran RG; Gibson RJ
    Epilepsia; 1998 Mar; 39(3):280-2. PubMed ID: 9578045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
    Sunder TR; McKee JR; Hammer AE; Vuongc A
    Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of lamotrigine on refractory epilepsies in persons with severe motor and intellectual disabilities].
    Adachi M; Kawasaki Y
    No To Hattatsu; 2012 Nov; 44(6):445-9. PubMed ID: 23240524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
    Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation.
    McKee JR; Sunder TR; FineSmith R; Vuong A; Varner JA; Hammer AE; Barrett PS
    Epilepsy Behav; 2003 Aug; 4(4):386-94. PubMed ID: 12899858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuropsychological aspects of cognitive functioning in epileptic children and adolescents treated with lamotrigine].
    Mojs E; Galas-Zgorzalewicz B; Steinborn B
    Neurol Neurochir Pol; 2000; 34 Suppl 1():153-64. PubMed ID: 10768155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lamotrigine in refractory epilepsy].
    García-Escrivà A; López-Hernández N; Alvarez-Saúco M; Pampliega-Pérez A; Oliver-Navarrete C; Asensio-Asensio M; Moltó-Jordá JM; Palao-Sánchez A
    Rev Neurol; 2004 Feb 16-29; 38(4):301-3. PubMed ID: 14997450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
    Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
    Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation.
    Davanzo PA; King BH
    J Child Adolesc Psychopharmacol; 1996; 6(4):273-9. PubMed ID: 9231320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine as add-on therapy in adult patients with refractory epilepsy.
    Yen DJ; Yiu CH; Kwan SY; Lin YY; Su MS
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 May; 59(5):303-7. PubMed ID: 9248123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lamotrigine in the adult-onset epilepsy: efficacy and long-term safety].
    Alegre M; Iriarte J; Schlumberger E; Urrestarazu E; Lázaro D; Viteri C
    Neurologia; 2002 Mar; 17(3):136-42. PubMed ID: 11927102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine use of lamotrigine, a new anti-epileptic medication, and the value of measuring its blood levels.
    Beran RG; Sheehan K; Tilley MI
    Clin Exp Neurol; 1994; 31():61-7. PubMed ID: 7586666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.
    Uvebrant P; Bauzienè R
    Neuropediatrics; 1994 Dec; 25(6):284-9. PubMed ID: 7770124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
    Gidal BE; Walker JK; Lott RS; Shaw R; Speth J; Marty KJ; Rutecki P
    Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
    Evans BK; Kustra RP; Hammer AE
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.